These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 23128449

  • 1. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y, Wang HD, Zhu L, Cong ZX, Li N, Ji XJ, Pan H, Wang JW, Li WC.
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Zhang L, Wang H.
    Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Nrf2 might enhance the anti-tumor effect of temozolomide in glioma cells via inhibition of Ras/Raf/MEK signaling pathway.
    Sun W, Zhang W, Yu J, Lu Z, Yu J.
    Int J Neurosci; 2021 Oct; 131(10):975-983. PubMed ID: 32378973
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH, Ma ZX, Huang GH, Xu QF, Xiang Y, Li N, Sidlauskas K, Zhang EE, Lv SQ.
    Exp Cell Res; 2016 May 01; 343(2):148-158. PubMed ID: 27090014
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan 01; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Wang Q, Qian J, Wang J, Luo C, Chen J, Hu G, Lu Y.
    J Neurooncol; 2013 Mar 01; 112(1):73-82. PubMed ID: 23292182
    [Abstract] [Full Text] [Related]

  • 8. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Rocha CR, Kajitani GS, Quinet A, Fortunato RS, Menck CF.
    Oncotarget; 2016 Jul 26; 7(30):48081-48092. PubMed ID: 27344172
    [Abstract] [Full Text] [Related]

  • 9. IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.
    Li K, Ouyang L, He M, Luo M, Cai W, Tu Y, Pi R, Liu A.
    Oncotarget; 2017 Apr 25; 8(17):28865-28879. PubMed ID: 28427200
    [Abstract] [Full Text] [Related]

  • 10. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
    Short SC, Giampieri S, Worku M, Alcaide-German M, Sioftanos G, Bourne S, Lio KI, Shaked-Rabi M, Martindale C.
    Neuro Oncol; 2011 May 25; 13(5):487-99. PubMed ID: 21363882
    [Abstract] [Full Text] [Related]

  • 11. Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma.
    Gratas C, Séry Q, Rabé M, Oliver L, Vallette FM.
    Oncotarget; 2014 May 15; 5(9):2428-35. PubMed ID: 24811082
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK.
    Neuro Oncol; 2013 May 15; 15(5):562-77. PubMed ID: 23444257
    [Abstract] [Full Text] [Related]

  • 13. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X.
    Exp Mol Med; 2015 Sep 04; 47(9):e182. PubMed ID: 26337869
    [Abstract] [Full Text] [Related]

  • 14. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy.
    Xu JX, Yang Y, Zhang X, Luan XP.
    Anat Rec (Hoboken); 2021 Feb 04; 304(2):342-352. PubMed ID: 32275350
    [Abstract] [Full Text] [Related]

  • 15. Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells.
    Cong ZX, Wang HD, Zhou Y, Wang JW, Pan H, Zhang DD, Zhang L, Zhu L.
    J Neurooncol; 2014 Jan 04; 116(1):41-8. PubMed ID: 24078215
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.
    Gao S, Yang XJ, Zhang WG, Ji YW, Pan Q.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1260-6. PubMed ID: 19567134
    [Abstract] [Full Text] [Related]

  • 17. All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.
    Shi L, Li H, Zhan Y.
    Oncol Lett; 2017 Sep 05; 14(3):2709-2714. PubMed ID: 28927033
    [Abstract] [Full Text] [Related]

  • 18. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells.
    Zhang C, Cai Z, Liang Q, Wang Q, Lu Y, Hu L, Hu G.
    Cell Mol Neurobiol; 2017 Apr 05; 37(3):555-562. PubMed ID: 27473470
    [Abstract] [Full Text] [Related]

  • 19. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH, Cheng CH, Shih CM, Ho KH, Lin CW, Lee CC, Liu AJ, Chang CK, Chen KC.
    PLoS One; 2016 Apr 05; 11(11):e0167096. PubMed ID: 27893811
    [Abstract] [Full Text] [Related]

  • 20. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
    Chen PH, Shen WL, Shih CM, Ho KH, Cheng CH, Lin CW, Lee CC, Liu AJ, Chen KC.
    Neuropharmacology; 2017 Apr 05; 116():300-314. PubMed ID: 27986595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.